ProCE Banner Activity

Exploring the Clinical Landscape of Novel HER3-Targeted Treatments for Advanced NSCLC


In this downloadable slideset, Rebecca S. Heist, MD, MPH, reviews up-to-date clinical data with HER3-targeted therapies for patients with advanced NSCLC.

Released: November 06, 2023



Rebecca S. Heist

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.